ABL Promoting US and French Sites at BIO-Europe Spring

Paris, France – February 25, 2015 – ABL will be attending EMD’s BIO-Europe Spring in Paris, France. The conference will take place in the Paris Expo – Porte de Versailles, Hall 5 on March 9-11.  ABL is excited to discuss clinical and preclinical immunoassay services in both the US and France, as well as other service offerings, including GMP manufacturing of vaccines and proteins.

To set up a meeting around the conference find us on the BIO-Europe Partnering system or contact us.

About ABL, Inc.

ABL, Inc. is a global biomedical contract research and manufacturing organization dedicated to advancing vaccines, therapeutics and other biologic products. ABL has extensive experience working with diverse organizations, including the U.S. Government, biopharmaceutical companies and academic entities. Notable contract manufacturing services include process and assay development, cGMP biologics manufacturing of bulk drug substance, cGMP aseptic fill and finish of drug product, and QC analytics in the U.S. and Europe. ABL also maintains U.S. and European immunological and molecular laboratories to support preclinical and GCLP clinical sample processing and testing. ABL is a part of the Institut Mérieux, a group of companies dedicated to developing translational science for better patient care globally.

For more information visit www.ablinc.com or email us.